Purpose: The safe and effective outpatient treatment of adults with chemotherapy- induced neutropenic fever is reviewed. Summary: Chemotherapy-induced neutropenic fever is a potentially life ...

Bear in mind that not all fevers cause sweating, though. If a patient has a neutropenic fever (a fever accompanied by low ...

In case of fever, blood cultures were obtained, and the patients were immediately started on intravenous cefepime, unless a previous episode of febrile neutropenia documented a cefepime-resistant ...

Possible symptoms include recurrent infections, fever, chills, and a chronic cough. There are a few ways to treat neutropenia ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

In a study of 32 patients with chemotherapy- induced neutropenic fever at Stanford University, the Karius test identified pathogens in 18 of 27 samples that had negative blood culture results.

Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood. Neutrophils ...

and the first large randomized trial comparing two agents for the empiric antifungal treatment of patients with persistent fever and neutropenia. The results of these studies have had an enduring ...

a type of white blood cell), febrile neutropenia (fever with neutropenia), diarrhea, intestinal obstruction, pyrexia (fever), pneumonia, respiratory failure, pulmonary embolism, decreased appetite and ...

The FDA has approved obecabtagene autoleucel (Aucatzyl) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Cyclophosphamide 500mg, 1g, 2g; per vial; pwd for inj after reconstitution; preservative-free. Cyclophosphamide is biotransformed principally in the liver to active alkylating metabolites by a ...

To reduce time to neutrophil recovery and fever duration after induction or consolidation chemotherapy treatment of adults with AML. To reduce duration of neutropenia and related sequelae in ...